TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T10484 XX ID T10484 XX DT 23.05.2007 (created); ask. DT 12.01.2012 (updated); yre. CO Copyright (C), QIAGEN. XX FA TEF-3-isoform1 XX SY RTEF-1; RTEF1; TEAD4; TEF3. XX OS human, Homo sapiens OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; primates XX GE G006801 TEAD4; HGNC: TEAD4. XX CL C0024; TEA. XX SZ 427 AA; 47.7 kDa (calc.). XX SQ MTSNEWSSPTSPEGSTASGGSQALDKPIDNDAEGVWSPDIEQSFQEALAIYPPCGRRKII SQ LSDEGKMYGRNELIARYIKLRTGKTRTRKQVSSHIQVLARRKAREIQAKLKDQAAKDKAL SQ QSMAAMSSAQIISATAFHSSMALARGPGRPAVSGFWQGALPGQAGTSHDVKPFSQQTYAV SQ QPPLPLPGFESPAGPAPSPSAPPAPPWQGRSVASSKLWMLEFSAFLEQQQDPDTYNKHLF SQ VHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIE SQ DEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLC SQ EYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHH SQ IYRLVKE XX SC translated from EMBL #X94438 XX FT 1 419 PF01285; TEA/ATTS domain family. FT 27 98 SM00426; TEA. FT 31 98 PS51088; TEA_2. FT 90 408 PF00478; IMP dehydrogenase / GMP reductase domain. XX IN T25956 YAP-isoform2; human, Homo sapiens. XX MX M07270 V$TEF3_Q3. XX BS R21294. BS R21285. BS R21293. BS R21291. BS R21292. BS R21296. BS R21295. BS R26432. BS R09232. BS R09221. BS R21290. BS R26314. XX DR TRANSPATH: MO000107542. DR EMBL: U63824; DR EMBL: X94438; DR UniProtKB: Q15561; XX RN [1]; RE0017315. RX PUBMED: 8702974. RA Jacquemin P., Hwang J. J., Martial J. A., Dolle P., Davidson I. RT A novel family of developmentally regulated mammalian transcription factors containing the TEA/ATTS DNA binding domain RL J. Biol. Chem. 271:21775-21785 (1996). RN [2]; RE0017316. RX PUBMED: 8921372. RA Stewart A. F., Richard III C. W., Suzow J., Stephan D., Weremowicz S., Morton C. C., Adra C. N. RT Cloning of human RTEF-1, a transcriptional enhancer factor-1-related gene preferentially expressed in skeletal muscle: evidence for an ancient multigene family RL Genomics 37:68-76 (1996). RN [3]; RE0071670. RX PUBMED: 20972459. RA Chan S. W., Lim C. J., Huang C., Chong Y. F., Gunaratne H. J., Hogue K. A., Blackstock W. P., Harvey K. F., Hong W. RT WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ. RL Oncogene 30:600-610 (2011). RN [4]; RE0071968. RX PUBMED: 21205866. RA Zhao B., Li L., Lu Q., Wang L. H., Liu C. Y., Lei Q., Guan K. L. RT Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. RL Genes Dev. 25:51-63 (2011). XX //